Has Kurt Wharton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,715 in general payments to Kurt Wharton, MD across 219 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kurt Wharton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kurt Wharton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kurt Wharton, MD

Radiation Oncology · Glendale, AZNPI 1457561086

Payments from drug & device makers

$6,715in general payments, 2019–2025

Across 219 payments — averaging $30.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Elekta, Inc.$559
Varian Medical Systems, Inc.$436
Blue Earth Diagnostics$394
Novocure Inc.$375
AstraZeneca$329
Johnson & Johnson$271
plus $4K from 54 others

What the payments were for

Food & beverage$6,715100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Elekta, Inc.	4	$559
Varian Medical Systems, Inc.	5	$436
Blue Earth Diagnostics	16	$394
Novocure Inc.	9	$375
AstraZeneca	11	$329
Johnson & Johnson	12	$271
Icotec Medical Inc.	2	$260
Takeda Pharmaceuticals U.S.A., Inc.	8	$191
Eisai Inc.	8	$186
Progenics Pharmaceuticals, Inc.	3	$179
Daiichi Sankyo Inc.	7	$177
Pfizer	8	$176
Novartis	9	$175
Myriad Genetic Laboratories, Inc.	6	$169
Molnlycke Health Care US, LLC	1	$165
Merck	7	$164
Regeneron Healthcare Solutions, Inc.	5	$161
Amgen	7	$144
AbbVie	6	$138
Accuray Incorporated	1	$119
Astellas Pharma US Inc	3	$118
Sanofi	5	$104
Bayer	5	$97
Blueprint Medicines Corporation	5	$96
Incyte Corporation	4	$95
GSK	5	$89
Medtronic	1	$79
Boehringer Ingelheim	3	$77
Lilly USA, LLC	3	$70
Verity Pharmaceuticals Inc.	4	$68
Genentech USA, Inc.	3	$65
Tersera Therapeutics LLC	2	$59
Genmab U.S., Inc.	2	$59
Seagen Inc.	3	$57
Bristol Myers Squibb	2	$57
Carbofix Spine Inc	1	$56
Puma Biotechnology, Inc.	2	$46
Exelixis Inc.	2	$46
Springworks Therapeutics, Inc.	2	$44
Coherus Oncology, Inc.	2	$43
AVEO Pharmaceuticals, Inc.	2	$42
EMD Serono, Inc.	2	$42
Kyowa Kirin, Inc.	2	$42
Rigel Pharmaceuticals, Inc.	2	$40
Pharmacosmos Therapeutics Inc.	1	$31
Bioprotect Medical, Inc.	1	$31
Pharming Healthcare, Inc.	1	$29
Karyopharm Therapeutics Inc.	1	$27
Adaptive Biotechnologies Corporation	1	$26
Jazz Pharmaceuticals Inc.	2	$26
Stemline Therapeutics Inc.	1	$23
CTI Biopharma Corp.	1	$23
Recordati_rare_diseases_inc.	1	$22
Tempus AI, Inc	1	$21
Ipsen Biopharmaceuticals, Inc	1	$19
Morphosys, US Inc.	1	$17
Fennec Pharmaceuticals, Inc.	1	$17
Legend Biotech USA Inc.	1	$16
Tolmar Pharmaceuticals, Inc.	1	$15
Digestive Care, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,715 in reported general payments places this provider in the 70th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024

$1,430,126

Medicare patients

481

Services billed

6,102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OrgovyxRelugolix	17	$44,316
Tamsulosin Hcl	119	$1,594
Pilocarpine Hcl	17	$1,412
Bicalutamide	38	$671
Lidocaine Hcl ViscousLidocaine Hcl	16	$351
Methylprednisolone	13	$131

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Glendale

Murali MurtyGlendale$17K
Patrick MillerGlendale$10K
Craig HullettGlendale$3K
Chi ZhangScottsdale$495K
Michael GarciaSun City$366K
Michael SamuelsGilbert$323K
John KreslPhoenix$251K
Terence SioScottsdale$221K
Nitika ThawaniPhoenix$199K
Carlos VargasScottsdale$179K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →